Nano Cap Stocks Alert: BGMD, CERP, CDII, HUSA, EDAP

Houston, TX -- (SBWIRE) -- 01/03/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.

BG Medicine, Inc. (NASDAQ:BGMD) is currently trading at $19.20, 2.77% higher. BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE, which is a multi-analyte biomarker-based blood test for atherothrombotic cardiovascular disease, commonly known as vulnerable plaque. In March 2011, the Company entered into a supply agreement with Health Diagnostic Laboratory, Inc. (HDL), pursuant to which HDL agreed to purchase manual galectin-3 test kits from the Company and to offer galectin-3 testing services to physicians in the United States.

How Should Investors Trade BGMD After The Recent Volatile Moves? Find Out Here

Cereplast, Inc. (PINK:CERP) fell 6.82% to $0.0205. Cereplast, Inc. (Cereplast) is engaged in developing and commercializing bio-based resins through two product families: Cereplast Compostables Resins, which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables resins (including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources. The Company primarily conducts its operations through product families, such as Cereplast Compostables resins, Cereplast Hybrid Resins and Cereplast Algae Plastic resins. In October 2011, the Company purchased a manufacturing plant in Assisi (Cannara).

Is CERP Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here

CD International Enterprises Inc (PINK:CDII) is lower 37.65% to $0.0530. CD International Enterprises, Inc., formerly China Direct Industries, Inc., sources, produces and distributes industrial products in China and the Americas. The Company also provides business and financial consulting services to public and private American and Chinese businesses. It operates in three business segments: Magnesium, Basic Materials and Consulting. It manages a portfolio of Chinese entities and also provides consulting services to Chinese businesses.

Can CDII Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

Houston American Energy Corporation (NYSE:HUSA) among the gainers and the stock added 1.11% to $0.228. Houston American Energy Corp (Houston American) is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties in the United States Gulf Coast region and in South America. The Company’s oil and gas reserves and operations are concentrated in the South American country of Colombia and in the onshore Gulf Coast region, particularly Texas and Louisiana.

Is HUSA Ready To Move Back To New Highs This Year? Find Out Here

EDAP TMS S.A. (ADR) (NASDAQ:EDAP) added 12.44% to $2.36. Edap Tms SA (EDAP) is engaged in developing and marketing the Ablatherm device, an advanced choice for high intensity focused ultrasound (HIFU) treatment of localized prostate cancer. The Company operates two divisions: HIFU and urology devices and services (UDS) (including lithotripsy activities). Through these two divisions, the Company develops, produces and markets minimally invasive medical devices, mainly for urological diseases HIFU treatment is shown to be a minimally invasive treatment option for localized prostate cancer with a low occurrence of side effects.

Is EDAP Ready To Move Back To New Highs This Year? Find Out Here

Disclaimer
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information
Winning Media LLC
1-800-411-7716
ir@AnotherWinningTrade.com